Evaluating ultrasound to predict postpartum hemorrhage risk
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
This study is testing if ultrasound exams done shortly after delivery can help predict the risk of bleeding complications for new mothers in the hours following childbirth.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1725 (estimated) |
| Ages | 17 Years and up |
| Sex | Female |
| Sponsor | Endeavor Health Academic / other |
| Locations | 1 site (Evanston, Illinois) |
| Trial ID | NCT06898034 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the use of ultrasound exams performed 1.5 to 2 hours after delivery to identify markers that may predict the risk of medium-term postpartum hemorrhage, which occurs between 1.5 to 24 hours post-delivery. The study will collect data on patients' medical and obstetrical history, labor and delivery outcomes, and details about postpartum bleeding. This information will be correlated with ultrasound results to enhance understanding of bleeding risks in postpartum patients. The goal is to improve early identification and management of potential hemorrhage.
Who should consider this trial
Good fit: Ideal candidates are English-speaking pregnant women planning to deliver at Endeavor Health who are more than 37 weeks gestational age and meet specific labor dilation criteria.
Not a fit: Patients who are non-English speaking, have preterm deliveries, or have conditions impairing decision-making may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better prediction and management of postpartum hemorrhage, potentially reducing complications for new mothers.
How similar studies have performed: While there is ongoing research into postpartum hemorrhage, this specific approach using ultrasound for medium-term risk assessment is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Currently pregnant and planning to deliver at Endeavor Health \>37 weeks gestational age * English speaking * Labor \<6cm dilated at time of consent without epidural * Labor \<8cm dilated at time of consent with epidural Exclusion Criteria: * Preterm delivery * Non-English speaking * Any conditions that impairs potential participants decision making
Where this trial is running
Evanston, Illinois
- Endeavor Health — Evanston, Illinois, United States (Recruiting)
Study contacts
- Study coordinator: Kate Honeyfield
- Email: KHoneyfield@northshore.org
- Phone: 847-570-2243
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.